Capping Copays Will Raise Premiums and Drug Prices

Most Americans have health coverage that includes some form of drug benefits. Cost-sharing is a method employers, insurers and drug plans use to hold down drug spending and keep premiums affordable by giving enrollees an incentive to ask for generic drugs when appropriate. Cost-sharing also provides drug makers with an incentive to limit excessive price hikes or risk alienating customers who could see their cost-sharing rise. If policymakers are successful in their attempts to limit cost-sharing, you can bet there will be even more drugs with prices that reach the stratosphere.

Click here to read the full publication →